GAM Systematic’s Xylem XYL Stock Holding History

GAM Systematic’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-22,131	Closed	-$1.1M	–	689
2016 Q4	$1.1M	Buy	+22,131	New	+$1.12M	0.26%	130

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAM Systematic's XYL Position: Q1 2017 in Review

GAM Systematic sold out of Xylem (XYL) in Q1 2017, closing a stake of 22,131 shares — an estimated $1.1M sold.

GAM Systematic first reported a position in XYL in Q4 2016 and held it in 1 quarter. The position peaked at $1.1M in Q4 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

GAM Systematic reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
GAM Systematic sold 22,131 Xylem shares in Q1 2017, an estimated $1.1M.
GAM Systematic first reported a position in Xylem in Q4 2016 and held it in 1 quarter.
GAM Systematic's Xylem position peaked at $1.1M in Q4 2016.
546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on GAM Systematic's 13F filing for Q1 2017, filed 15 May 2017.